about
A diverse array of genetic factors contribute to the pathogenesis of systemic lupus erythematosusEpigenetics of Peripheral B-Cell Differentiation and the Antibody ResponseMetabolic control of the epigenome in systemic Lupus erythematosus.Epigenetics of autoantigens: new opportunities for therapy of autoimmune diseases.Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses.Histone deacetylase inhibitors for treating a spectrum of diseases not related to cancerHistone/protein deacetylases and T-cell immune responsesThe dark side of regulatory T cells in psoriasisHDAC expression and activity is upregulated in diseased lupus-prone mice.Histone deacetylases inhibitor Trichostatin A ameliorates DNFB-induced allergic contact dermatitis and reduces epidermal Langerhans cells in miceEpigenetics of the antibody responseClass I and II histone deacetylase inhibition by ITF2357 reduces SLE pathogenesis in vivo.Epigenetics and psoriasis.Modulation of antigen-presenting cells by HDAC inhibitors: implications in autoimmunity and cancer.The therapeutic potential of epigenetics in autoimmune diseases.Exploring the epigenetic drug discovery landscape.Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective.Natural antisense RNAs are involved in the regulation of CD45 expression in autoimmune diseases.Curcumol Controls Choriocarcinoma Stem-Like Cells Self-Renewal via Repression of DNA Methyltransferase (DNMT)- and Histone Deacetylase (HDAC)-Mediated Epigenetic Regulation.Manipulation of B-cell responses with histone deacetylase inhibitors.
P2860
Q22299119-D05C4509-3312-4F20-BD42-DFE04E3A16B1Q26772330-CC4E8D4F-582C-4BC5-8790-934EE97B6A9AQ33664849-9BAE5261-8251-4526-88B4-42290A905F5EQ34463063-68D6B83F-EC69-4598-83DA-F5484CE6BEF3Q34647217-7BDA0967-FF26-405F-8F46-8C0BF234BCD3Q35016934-5384018D-A3B5-46E7-9B0B-C6479CEE6729Q35849307-A2E267B6-325B-41C1-8460-75A0C5EE5951Q36005466-F114F379-3227-4904-A7D9-E36D7A6C12DAQ36338516-A36B902C-3D49-426E-ADAD-0B7188D9739EQ36351364-DC8EDD1A-2693-4A0F-8AA8-C6ED598FF2B6Q37097751-F8EF64A6-0223-462D-8946-CC9DEEF80592Q37657613-56794C4A-2BD6-4E3A-8AF5-1E0015CE9948Q37933446-7195102D-6F2C-4A3D-8457-BC6D5FDE8DB2Q37959304-96BB9FC5-C5A8-407C-8EBF-6C74116D7CFBQ37967566-4CA8D6DB-7616-4A5E-92AE-93DE2BD12284Q38748410-A93CD618-BA43-469B-8886-15A583AA8822Q39379152-AA85C92A-FACC-4394-B4A3-F9E7C3299BEDQ47972361-989C6F1E-8BE8-4936-8887-FF5F9A9246FFQ49464667-D59634B0-3F43-4DF8-9041-A1F5E3A92B0CQ50738767-75D41807-4CFE-4448-97E6-602BD4BD2AA8
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
HDAC inhibition in lupus models.
@ast
HDAC inhibition in lupus models.
@en
type
label
HDAC inhibition in lupus models.
@ast
HDAC inhibition in lupus models.
@en
prefLabel
HDAC inhibition in lupus models.
@ast
HDAC inhibition in lupus models.
@en
P2093
P2860
P1433
P1476
HDAC inhibition in lupus models.
@en
P2093
Christopher M Reilly
Nicole Regna
Nilamadhab Mishra
P2860
P2888
P304
P356
10.2119/MOLMED.2011.00055
P407
P577
2011-02-11T00:00:00Z
P5875
P6179
1068965375